Literature DB >> 26689753

Transport across Schlemm's canal endothelium and the blood-aqueous barrier.

Sietse T Braakman1, James E Moore1, C Ross Ethier2, Darryl R Overby3.   

Abstract

The majority of trabecular outflow likely crosses Schlemm's canal (SC) endothelium through micron-sized pores, and SC endothelium provides the only continuous cell layer between the anterior chamber and episcleral venous blood. SC endothelium must therefore be sufficiently porous to facilitate outflow, while also being sufficiently restrictive to preserve the blood-aqueous barrier and prevent blood and serum proteins from entering the eye. To understand how SC endothelium satisfies these apparently incompatible functions, we examined how the diameter and density of SC pores affects retrograde diffusion of serum proteins across SC endothelium, i.e. from SC lumen into the juxtacanalicular tissue (JCT). Opposing retrograde diffusion is anterograde bulk flow velocity of aqueous humor passing through pores, estimated to be approximately 5 mm/s. As a result of this relatively large through-pore velocity, a mass transport model predicts that upstream (JCT) concentrations of larger solutes such as albumin are less than 1% of the concentration in SC lumen. However, smaller solutes such as glucose are predicted to have nearly the same concentration in the JCT and SC. In the hypothetical case that, rather than micron-sized pores, SC formed 65 nm fenestrae, as commonly observed in other filtration-active endothelia, the predicted concentration of albumin in the JCT would increase to approximately 50% of that in SC. These results suggest that the size and density of SC pores may have developed to allow SC endothelium to maintain the blood-aqueous barrier while simultaneously facilitating aqueous humor outflow.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biological transport phenomena; Blood-aqueous barrier; Diffusion; Glaucoma; Schlemm's canal endothelium

Mesh:

Year:  2015        PMID: 26689753      PMCID: PMC4893895          DOI: 10.1016/j.exer.2015.11.026

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  31 in total

1.  Filtration, diffusion, and molecular sieving through porous cellulose membranes.

Authors:  E M RENKIN
Journal:  J Gen Physiol       Date:  1954-11-20       Impact factor: 4.086

2.  Certain physical properties of bovine prothrombin.

Authors:  F LAMY; D F WAUGH
Journal:  J Biol Chem       Date:  1953-07       Impact factor: 5.157

3.  The source of protein in the aqueous humor of the normal monkey eye.

Authors:  M F Barsotti; S P Bartels; T F Freddo; R D Kamm
Journal:  Invest Ophthalmol Vis Sci       Date:  1992-03       Impact factor: 4.799

Review 4.  'What controls aqueous humour outflow resistance?'.

Authors:  Mark Johnson
Journal:  Exp Eye Res       Date:  2006-01-04       Impact factor: 3.467

5.  Experimental aqueous perfusion in enucleated human eyes. Results after obstruction of Schlemm's canal.

Authors:  V L Jocson; M L Sears
Journal:  Arch Ophthalmol       Date:  1971-07

Review 6.  Interstitial-lymphatic mechanisms in the control of extracellular fluid volume.

Authors:  K Aukland; R K Reed
Journal:  Physiol Rev       Date:  1993-01       Impact factor: 37.312

7.  Effect of fixation pressure on juxtacanalicular tissue and Schlemm's canal.

Authors:  R D Ten Hulzen; D H Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-01       Impact factor: 4.799

8.  Ocular rigidity, ocular pulse amplitude, and pulsatile ocular blood flow: the effect of intraocular pressure.

Authors:  Anna I Dastiridou; Harilaos S Ginis; Dirk De Brouwere; Miltiadis K Tsilimbaris; Ioannis G Pallikaris
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-15       Impact factor: 4.799

9.  Protein composition of human aqueous humor: SDS-PAGE analysis of surgical and post-mortem samples.

Authors:  R C Tripathi; C B Millard; B J Tripathi
Journal:  Exp Eye Res       Date:  1989-01       Impact factor: 3.467

10.  Aqueous humour glucose concentration in cataract patients and its effect on the lens.

Authors:  P D Davies; G Duncan; P B Pynsent; D L Arber; V A Lucas
Journal:  Exp Eye Res       Date:  1984-11       Impact factor: 3.467

View more
  6 in total

1.  A bioengineering approach to Schlemm's canal-like stem cell differentiation for in vitro glaucoma drug screening.

Authors:  Yangzi Isabel Tian; Xulang Zhang; Karen Torrejon; John Danias; Sofya Gindina; Ashima Nayyar; Yiqin Du; Yubing Xie
Journal:  Acta Biomater       Date:  2020-01-23       Impact factor: 8.947

Review 2.  Progress in the basic and clinical research on the Schlemm's canal.

Authors:  Le-Ying Wang; Guan-Yu Su; Zhen-Yu Wei; Zi-Jun Zhang; Qing-Feng Liang
Journal:  Int J Ophthalmol       Date:  2020-05-18       Impact factor: 1.779

Review 3.  The vital role for nitric oxide in intraocular pressure homeostasis.

Authors:  Ester Reina-Torres; Michael L De Ieso; Louis R Pasquale; Michael Madekurozwa; Joseph van Batenburg-Sherwood; Darryl R Overby; W Daniel Stamer
Journal:  Prog Retin Eye Res       Date:  2020-11-28       Impact factor: 21.198

Review 4.  Immune responses to injury and their links to eye disease.

Authors:  Mary Ann Stepp; A Sue Menko
Journal:  Transl Res       Date:  2021-05-27       Impact factor: 10.171

5.  Constructal approach to bio-engineering: the ocular anterior chamber temperature.

Authors:  Umberto Lucia; Giulia Grisolia; Daniela Dolcino; Maria Rosa Astori; Eugenio Massa; Antonio Ponzetto
Journal:  Sci Rep       Date:  2016-08-05       Impact factor: 4.379

6.  Enhancement of Outflow Facility in the Murine Eye by Targeting Selected Tight-Junctions of Schlemm's Canal Endothelia.

Authors:  Lawrence C S Tam; Ester Reina-Torres; Joseph M Sherwood; Paul S Cassidy; Darragh E Crosbie; Elke Lütjen-Drecoll; Cassandra Flügel-Koch; Kristin Perkumas; Marian M Humphries; Anna-Sophia Kiang; Jeffrey O'Callaghan; John J Callanan; A Thomas Read; C Ross Ethier; Colm O'Brien; Matthew Lawrence; Matthew Campbell; W Daniel Stamer; Darryl R Overby; Pete Humphries
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.